Cargando…
Insulin Glargine: A Reevaluation of Rodent Carcinogenicity Findings
The 1995 to 1997 lifetime carcinogenicity studies of insulin glargine in rats and mice were reanalyzed and reassessed for their validity according to current guidelines. In 2-year studies, 50 animals per sex and per group were used. Survival rates between weeks 80 and 90 in female mice and rats were...
Autores principales: | Stammberger, Ingo, Essermeant, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325594/ https://www.ncbi.nlm.nih.gov/pubmed/22215409 http://dx.doi.org/10.1177/1091581811431111 |
Ejemplares similares
-
Identification of arboviruses and certain rodent-borne viruses: reevaluation of the paradigm.
Publicado: (2001) -
Insulin glargine overdose
por: Doğan, Fatma Sarı, et al.
Publicado: (2012) -
Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016) -
Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database.
por: Gold, L S, et al.
Publicado: (1989) -
Insulin glargine and the risk of cancer
por: Ahmed, FA
Publicado: (2010)